What is Ceres Ventures, Inc. (CEVE) stock price today?

Ceres Ventures, Inc. (CEVE) is currently trading at $0.00.

What is CEVE P/E ratio?

Ceres Ventures, Inc.'s P/E ratio is -0.01. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CEVE return on equity (ROE)?

Ceres Ventures, Inc.'s return on equity (ROE) is 225.93%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Ceres Ventures, Inc.'s market cap?

Ceres Ventures, Inc. has a market capitalization of $8550.

OTC · Medical - Care Facilities

Ceres Ventures, Inc. (CEVE) Stock

$0.00 OTC: CEVE Healthcare

Ceres Ventures, Inc. is an emerging clean technology firm dedicated to developing and bringing to market innovative environmental solutions aimed at purifying contaminated water, soil, and air.

Valuation

Metric	Value
Price	$0.00
Market Cap	$8550
P/E Ratio	-0.01
P/B Ratio	-0.02
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	225.93%
ROA	-346.69%
ROCE	149.81%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.28
Current Ratio	0.02

Annual Financials (USD)

Metric	2007	2008	2009	2010	2011
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-2.0M	$-1.0M	$-1.0M	$2.0M	$-1.0M
Net Profit	$-2.0M	$-2.0M	$-1.0M	$2.0M	$-1.0M
EPS	$-0.50	$-0.50	$-0.17	$0.50	$-0.01
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2007	2008	2009	2010	2011
Total Assets	$2.0M	$1.0M	$0	$0	$0
Total Liabilities	$1.0M	$1.0M	$1.0M	$0	$1.0M
Cash	$2.0M	$1.0M	$0	$0	$0
Borrowings	$1.0M	$1.0M	$1.0M	$0	$0

Cash Flow (USD)

Metric	2007	2008	2009	2010	2011
Operating Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$2.0M	$-2.0M	$-1.0M	$0	$0
Free Cash Flow	$-1.0M	$-2.0M	$-1.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.01
FCF Yield	-3035.82%
Quick Ratio	0.21
Interest Coverage	-534.64
Return 1Y	0.00%
Return 3Y	0.00%
Return 5Y	-99.74%

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ASFXAmerican Scientific Resources, Incorporated	$0.00	—	—	$5251	0.00%
CBGIThe CannaBusiness Group, Inc.	$0.00	—	0.00	$1831	0.00%
HSMDHealthcare Solutions Management Group, Inc.	$0.00	—	0.00	$18443	0.00%
LOWLFLowell Farms Inc.	$0.00	—	0.00	$1815	0.00%
MDITMedite Cancer Diagnostics, Inc.	$0.00	—	0.00	$8672	0.00%

About Ceres Ventures, Inc.

Ceres Ventures, Inc. is an emerging clean technology firm dedicated to developing and bringing to market innovative environmental solutions aimed at purifying contaminated water, soil, and air. The company's core technological offerings comprise: BluFlow Nanoparticles: A proprietary system that engineers and deploys tailor-made absorbent nanoparticles. These microscopic particles are designed to precisely capture and remove various contaminants and chemicals, and can also be utilized to recover valuable elements and compounds from aquatic environments. BluFlow Advanced Ultrafiltration Technology: An automated ultrafiltration process focused on reclaiming clean water from industrial waste streams and other impure liquid sources. The BluFlow Treatment System, which integrates both the Nanoparticle and Advanced Ultrafiltration technologies. This comprehensive solution effectively eliminates a broad spectrum of pollutants, compounds, and undesirable elements, rendering water sufficiently pure for potential reuse. These solutions find diverse applications, including municipal and industrial water and wastewater purification, remediation of tainted groundwater, and the extraction of valuable resources from various solutions. Previously operating as PhytoMedical Technologies, Inc., the company adopted its current name, Ceres Ventures, Inc., in November 2011. Its headquarters are located in New York, New York.

Ceres Ventures, Inc. (CEVE) stock trades at $0.00 with a market capitalization of $8550. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.02, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Ceres Ventures, Inc. generates a return on equity (ROE) of 225.93% — well above the market average, a sign of a high-quality business, return on capital employed of 149.81%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: ceres.ventures

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides